Jack Lin

SFBN Feed: Cancer leaders lay out an optimistic vision for how AI will enhance patient care https://lnkd.in/gQ_UfZew SAN FRANCISCO — Leading oncologists said this week that artificial intelligence will one day be as integrated into cancer care as it is in smartphones and self-driving cars — and that this is a change [...] #BayArea #SanFrancisco #Biotech #Lifescience #News

1

Curative AI Takes 18,500 SQFT in Bellevue Sublease as Healthcare Startup Joins AI Migration to Eastside - https://lnkd.in/g9cfNvej Health tech company subleases One Bellevue Center space from departing gaming firm Niantic Bellevue’s downtown core continues to draw artificial intelligence companies seeking expansion space, with healthcare startup Curative AI becoming the latest to establish operations in the Eastside business district. The AI-focused health technology firm has secured 18,527 square feet at One Bellevue Center […]

4

New! Beyond Named Entity Recognition: A Comprehensive #NLP Framework for #HPO Phenotype Classification from Clinical Notes. From free-text documents to normalized HPO codes; now included with John Snow Labs Medical Language Models subscription. #ai #datascience #generativeai #llm #phenotype #medicalcoding #textmining #healthcareai https://lnkd.in/eVaMTp_X

16

Lunai Bioworks has landed at PMWC - Precision Medicine World Conference (PMWC) 2026 in Santa Clara (March 4–6), and we’d love to connect with partners focused on translation-first drug discovery, especially in neurology. If you’re attending PMWC, we hope you’ll join Gabriel Musso, our Chief Scientific Officer, for his talk on Friday, March 6, 2026 (11:45 a.m.–12:00 p.m. PST) in the AI in Drug Discovery & Computational Biology track: “From Prediction to Translation: AI and In Vivo Validation to Improve Drug Development Success.” He’ll share how a closed-loop workflow pairing predictive AI with high-throughput in vivo validation in neurological disease models can help prioritize hits and improve biological relevance. At Lunai Bioworks, our Augusta platform couples predictive AI with high-throughput in vivo validation to help improve translational confidence. We’re also building Sentinel™ as part of our biodefense work, designed to detect and block the generation of harmful chemical compounds in generative AI systems. If you’re at PMWC and working on patient stratification, biomarker discovery, or translation-ready validation strategies for neurology or biodefense programs, we’d welcome the chance to compare notes and explore partnering options. Reach out to schedule a time to connect. 🔗 Contact us: https://lnkd.in/gwgsTAR5 🔗 Email us: hello@lunaibioworks.com 🔗 Learn more about Lunai Bioworks: https://lnkd.in/gTnxDqfa #PMWC2026 #DrugDiscovery #ArtificialIntelligence #MachineLearning #Neurology #Biodefense #TranslationalScience #ComputationalBiology #BiotechPartnering #Biotech

10

CMS 0057 mandates a set of requirements that health plans have to adhere to, starting Jan 2027. Organizations partnering with Autonomize AI are on their way towards full compliance. Take a look at the toolkit the team put together for all plans to become complaint. #AI

13

🏆 Redwood Neuro wins $500K NIH Phase I SBIR to transform Alzheimer’s diagnostics 🏆 🧠 Alzheimer’s disease is often diagnosed too late, at which time treatment options are limited. At Redwood Neuro, Dr. Murat Baday is collaborating with University of California, Santa Cruz’s Dr. Ali A Yanik to develop a simple, affordable blood test that brings ultra-sensitive biomarker detection into routine care, thus enabling earlier intervention. 🧪 To fund the development of their SiMoLiSA™ platform for high-sensitivity Alzheimer’s detection, Redwood Neuro partnered with Eva Garland Consulting, LLC (EGC) to secure $500K in non-dilutive Phase I SBIR funding from the National Institute on Aging (NIA). EGC’s Scientific Grants Expert, Dr. Xiaohu Xie, partnered with the team to refine the application and manage submission, while Accounting & Compliance Expert, Nadine Galvez CPA, led JIT and award setup to ensure audit-ready financial and compliance systems were in place from day one.  🎉 Congratulations to the Redwood Neuro team on this milestone award!  EGC is proud to provide Redwood Neuro with this end-to-end support so they can focus on what matters most, bringing accessible Alzheimer’s diagnostics within reach for patients and families. #SBIR #NIH #NIA #Alzheimers #Neurodegeneration #BrainHealth #Biotech #NonDilutiveFunding #EGCwins

20

1 Comment

UC Davis saw a 36% increase in records of invention (ROIs) in FY 2025, reversing a multiyear decline and reflecting a vibrant surge in research innovation, especially in health-focused fields like gene therapy, neuroscience and oncology. Over 70% of ROIs came from first-time inventors, suggesting that a strong, inclusive culture of commercialization is growing across the Davis and Sacramento campuses. From CRISPR-engineered cartilage to a faster, more cost-effective manufacturing process for gene therapy, UC Davis research continues to translate into breakthroughs that will improve people's lives. This momentum is more than a metric—it’s a movement. Read more: https://lnkd.in/gY8zUt3H #Innovation #TechTransfer #AcademicResearch #HealthInnovation #UCDavis #UCDavisHealth #Commercialization #AggieSquare

29